Cypress Capital’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $230K | Sell |
7,519
-233
| -3% | -$7.11K | 0.07% | 84 |
|
|
2025
Q1 | $209K | Sell |
7,752
-510
| -6% | -$13.8K | 0.06% | 77 |
|
|
2024
Q4 | $297K | Sell |
8,262
-834
| -9% | -$29.9K | 0.08% | 66 |
|
|
2024
Q3 | $345K | Sell |
9,096
-338
| -4% | -$12.8K | 0.09% | 70 |
|
|
2024
Q2 | $427K | Sell |
9,434
-992
| -10% | -$44.9K | 0.11% | 71 |
|
|
2024
Q1 | $506K | Buy |
10,426
+208
| +2% | +$10.1K | 0.14% | 59 |
|
|
2023
Q4 | $548K | Sell |
10,218
-421
| -4% | -$22.6K | 0.16% | 56 |
|
|
2023
Q3 | $624K | Sell |
10,639
-1,609
| -13% | -$94.3K | 0.18% | 54 |
|
|
2023
Q2 | $772K | Buy |
12,248
+21
| +0.2% | +$1.32K | 0.22% | 55 |
|
|
2023
Q1 | $769K | Sell |
12,227
-358
| -3% | -$22.5K | 0.24% | 47 |
|
|
2022
Q4 | $670K | Sell |
12,585
-46
| -0.4% | -$2.45K | 0.21% | 61 |
|
|
2022
Q3 | $708K | Sell |
12,631
-871
| -6% | -$48.8K | 0.25% | 61 |
|
|
2022
Q2 | $977K | Sell |
13,502
-175
| -1% | -$12.7K | 0.14% | 108 |
|
|
2022
Q1 | $1.09M | Buy |
13,677
+1,290
| +10% | +$103K | 0.13% | 113 |
|
|
2021
Q4 | $1.25M | Sell |
12,387
-1,734
| -12% | -$176K | 0.14% | 113 |
|
|
2021
Q3 | $1.3M | Buy |
14,121
+250
| +2% | +$23.1K | 0.17% | 102 |
|
|
2021
Q2 | $1.42M | Sell |
13,871
-100
| -0.7% | -$10.2K | 1.39% | 36 |
|
|
2021
Q1 | $1.36M | Sell |
13,971
-223
| -2% | -$21.8K | 0.56% | 36 |
|
|
2020
Q4 | $1.09M | Sell |
14,194
-219
| -2% | -$16.9K | 0.5% | 43 |
|
|
2020
Q3 | $1.13M | Sell |
14,413
-622
| -4% | -$48.7K | 0.52% | 37 |
|
|
2020
Q2 | $1.1M | Buy |
+15,035
| New | +$1.1M | 0.49% | 37 |
|
|
2019
Q4 | $1.33M | Sell |
16,876
-926
| -5% | -$72.8K | 0.56% | 26 |
|
|
2019
Q3 | $1.22M | Sell |
17,802
-1,679
| -9% | -$115K | 0.56% | 24 |
|
|
2019
Q2 | $1.55M | Sell |
19,481
-2,623
| -12% | -$208K | 0.7% | 20 |
|
|
2019
Q1 | $1.85M | Sell |
22,104
-2,736
| -11% | -$229K | 0.77% | 18 |
|
|
2018
Q4 | $2.92M | Buy |
+24,840
| New | +$2.92M | 1.34% | 13 |
|